Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemical Synapses01:26

Chemical Synapses

12.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.8K
Chemical Synapses01:26

Chemical Synapses

10.5K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
10.5K
Layers of Connective Tissue Proper01:21

Layers of Connective Tissue Proper

8.4K
Fascia, a thin layer of fibrous connective tissue, is distributed throughout the body. It demarcates and forms a supportive covering over skeletal muscles, bones, blood vessels, and organs. There are three main types of facia— superficial fascia, deep fascia, and subserous fascia. These are all present at different depths in the body. Fascia reduces the friction and permits muscles, joints, and organs to easily slide against each other, facilitating movement of the body and preventing...
8.4K
Disorders of the Autonomic Nervous System01:18

Disorders of the Autonomic Nervous System

2.0K
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
2.0K
Muscle Stimulation Frequency01:22

Muscle Stimulation Frequency

5.2K
The contraction strength of muscles is regulated by motor neurons, which modulate the frequency of action potentials dispatched to the motor units based on the body's requirements. This process of varying the muscle stimulation frequency allows muscles to contract with a force that is precisely tailored to the needs of the moment, whether lifting a feather or a heavy box.
Wave summation
At low firing rates, motor neurons induce individual twitch contractions in muscle fibers. These twitches...
5.2K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

6.5K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
6.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medication Overuse Headache.

Journal of pain & palliative care pharmacotherapy·2016
Same journal

Cancer Patients with Neuropathic Pain: Pharmacist-Led Recommendation and Management and Mirogabalin Outcomes in a Single-Center Retrospective Observational Cohort.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

Cost-Effectiveness of Integrative Pain Management for Chronic Pain: A Systematic Review of Economic Evaluation.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

High-Dose Monotherapy or Combination Therapy in Neuropathic Pain: A Necessary Reflection.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

The Price of Goodbye.

Journal of pain & palliative care pharmacotherapy·2026
Same journal

In the End, What Shall We Say?

Journal of pain & palliative care pharmacotherapy·2026
Same journal

The Use of Ketamine for Depression in Cancer Patients: A Systematic Review of Efficacy, Safety, and Clinical Applications.

Journal of pain & palliative care pharmacotherapy·2026
See all related articles

Related Experiment Video

Updated: Apr 17, 2026

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

15.1K

Benign fasciculation syndrome.

Thomas Robert Walter

    Journal of Pain & Palliative Care Pharmacotherapy
    |February 21, 2015
    PubMed
    Summary
    This summary is machine-generated.

    This content addresses patient questions on pain management and medications. It specifically details benign fasciculation syndrome, including its causes, treatment, and relation to amyotrophic lateral sclerosis.

    Keywords:
    amyotrophic lateral sclerosisbenign fasciculation syndromecramp fasciculation syndromemuscle twitch

    More Related Videos

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
    04:30

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

    Published on: March 8, 2024

    2.0K
    TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
    10:58

    TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

    Published on: December 28, 2010

    17.6K

    Related Experiment Videos

    Last Updated: Apr 17, 2026

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
    05:54

    MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

    Published on: December 13, 2017

    15.1K
    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
    04:30

    Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models

    Published on: March 8, 2024

    2.0K
    TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism
    10:58

    TMS: Using the Theta-Burst Protocol to Explore Mechanism of Plasticity in Individuals with Fragile X Syndrome and Autism

    Published on: December 28, 2010

    17.6K

    Area of Science:

    • Neurology
    • Pain Management
    • Patient Education

    Background:

    • Patients frequently have questions regarding pain conditions and pharmacotherapy.
    • Effective patient advocacy requires clear understanding of medical conditions and treatments.

    Purpose of the Study:

    • To educate patients on pain conditions and analgesic pharmacotherapy.
    • To provide detailed information on benign fasciculation syndrome (BFS).
    • To clarify the relationship between BFS and amyotrophic lateral sclerosis (ALS).

    Main Methods:

    • Compilation of patient questions and author responses.
    • Review of literature on benign fasciculation syndrome.
    • Analysis of diagnostic criteria and treatment options for BFS.
    • Evaluation of epidemiological data linking BFS to ALS.

    Main Results:

    • Patient inquiries cover various pain conditions and medication use.
    • Benign fasciculation syndrome is characterized by specific presentations and causes.
    • Treatment strategies for BFS aim to manage symptoms.
    • The risk of developing amyotrophic lateral sclerosis from BFS is minimal.

    Conclusions:

    • Patient education empowers individuals to become effective self-advocates in managing pain.
    • Understanding benign fasciculation syndrome reassures patients about its generally benign nature.
    • Distinguishing BFS from ALS is crucial for appropriate patient management and prognosis.